January 25, 2023
January 25, 2023 —
Working with mice, Salk Institute researchers, in collaboration with the University of California San Diego, have identified another factor contributing to diabetes-associated peripheral neuropathy: altered amino acid metabolism.
December 7, 2015
December 7, 2015 —
Currently, there is no treatment to halt the progression of Huntington’s disease (HD), a fatal genetic disorder that slowly robs sufferers of their physical and mental abilities. Now, researchers at University of California, San Diego School of Medicine have discovered that an existing compound, previously tested for diabetes, offers hope…
April 21, 2023
April 21, 2023 —
UC San Diego researchers describe a key player in the defense mechanism that safeguards against excessive insulin in the body, which can be as harmful as too little.
January 21, 2021
January 21, 2021 —
…saliva samples, then on patients and healthcare workers at Veterans Affairs San Diego Healthcare System. Co-investigators on the team are William Penny, professor of clinical medicine, and cardiologist at VA San Diego Healthcare System, Louise Laurent, professor of obstetrics, gynecology and reproductive sciences, and Rob Knight, professor of pediatrics, bioengineering…
June 22, 2017
June 22, 2017 —
5G capabilities will make it possible to harness sensor technologies, virtual reality, artificial intelligence and machine learning for unprecedented applications—applications discussed at length during the conference.
August 23, 2012
August 23, 2012 —
…for others’ health and safety, and the consequences of mistakes. Finally, a bridging parameter was used to account for the dilemma faced by so many college graduates struggling to find the right job in today’s economy: Can entry requirements for this field be met in two years or less by…
July 24, 2020
July 24, 2020 —
UC San Diego Health and the Altman Clinical and Translational Research Institute will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the coronavirus that causes COVID-19.
June 17, 2020
June 17, 2020 —
Nanoparticles cloaked in human lung cell membranes and human immune cell membranes can attract and neutralize the SARS-CoV-2 virus in cell culture, causing the virus to lose its ability to hijack host cells and reproduce.
December 17, 2020
December 17, 2020 —
…available to all recent patients within the UC San Diego Health System on Nov. 23, growing the user base by up to 350,000 in the San Diego region. As a result, more than 50 COVID-19 exposure notifications have already been anonymously triggered to help protect the campus community. Q. How…
February 17, 2021
February 17, 2021 —
The Psychedelics and Health Research Initiative at UC San Diego has received a $1.3 million grant from the Steven & Alexandra Cohen Foundation to fund a clinical trial investigating the therapeutic potential of psilocybin in treating phantom limb pain.